IP Library Granted Patent US 7,514,469
Granted Patent B2
US 7,514,469 · App. 10/427,746 · Granted Apr 7, 2009

Formulation of a mixture of Free-B-ring flavonoids and flavans as a therapeutic agent

Assignee: Unigen Pharmaceuticals, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,514,469
App. No.
10/427,746
Granted
Apr 7, 2009
Kind
B2
Abstract

The present invention provides a novel composition of matter comprised of a mixture of two specific classes of compounds—Free-B-ring flavonoids and flavans—for use in the prevention and treatment of diseases and conditions mediated by the COX-2 and 5-LO pathways. The present invention further provides a novel method for simultaneously inhibiting the cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LO) enzymes, and reducing cox-2 mRNA production. Finally, the present invention includes a method for weight loss and blood glucose control. The methods of this invention are comprised of administering to a host in need thereof an effective amount of the composition of this invention together with a pharmaceutically acceptable carrier. This invention relates generally to the prevention and treatment of diseases and conditions mediated by the cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LO) pathways, including but not limited to the relief joint discomfort and pain associated with conditions such as osteoarthritis, rheumatoid arthritis, and other injuries that result from overuse.

Claims (22)

1. A method for alleviating joint pain and stiffness and improving mobility, range of motion and flexibility and physical function comprising administering to a host in need thereof an effective amount of a composition comprised of a mixture of an extract derived from Scutellaria enriched for Free-B-ring flavonoids containing baicalin and an extract derived from Acacia enriched for flavans containing catechin or epicatechin, wherein said method alleviates inflammation.

2. The method of claim 1 wherein the composition is administered in a dosage selected from 0.01 to 200 mg/kg of body weight.

3. The method of claim 1 wherein the routes of the administration are selected from the group consisting of oral, topical, suppository, intravenous, and intradermic, intragaster, intramusclar, intraperitoneal and intravenous administration.

4. The method of claim 1 wherein the ratio of Free-B-ring flavanoids:flavans in the composition of matter is about 85:15.

5. The method of claim 1 wherein said Free-B-ring flavonoids and said flavans are isolated from a plant part selected from the group consisting of stems, stem barks, trunks, trunk barks, twigs, tubers, roots, root barks, young shoots, seeds, rhizomes, flowers and other reproductive organs, leaves and other aerial parts.

6. The method claim 1 wherein said flavans are isolated from a plant species selected from the group consisting of the Acacia catechu, Acacia concinna, Acacia farnesiana, Acacia Senegal, Acacia speciosa, Acacia arabica, A. caesia, A. pennata, A. sinuata. A. mearnsii, A. picnantha, A. dealbata, A. auriculformis, A. holoserecia and A. mangium.

7. A method for treating pathological conditions related to osteoarthritis and rheumatoid arthritis, said method comprising administering to a host in need thereof an effective amount of a composition comprising a mixture of an extract derived from Scutellaria enriched for Free-B-ring flavonoids containing baicalin and an extract derived from Acacia enriched for flavans containing catechin or epicatechin together with a pharmaceutically acceptable carrier, wherein said method alleviates inflammation.

8. The method of claim 7 wherein the composition is administered in a dosage selected from 0.01 to 200 mg/kg of body weight.

9. The method of claim 7 wherein the routes of the administration are selected from the group consisting of oral, topical, suppository, intravenous, and intradermic, intragaster, intramusclar, intraperitoneal and intravenous administration.

10. The method of claim 7 wherein the ratio of Free-B-ring flavonoids:flavans in the composition of matter is about 85:15.

11. The method of claim 7 wherein said Free-B-ring flavonoids and said flavans are isolated from a plant part selected from the group consisting of stems, stem barks, trunks, trunk barks, twigs, tubers, roots, root barks, young shoots, seeds, rhizomes, flowers and other reproductive organs, leaves and other aerial parts.

12. The method claim 7 wherein said flavans are isolated from a plant species selected from the group consisting of the Acacia catechu, Acacia concinna, Acacia farnesiana, Acacia Senegal, Acacia speciosa, Acacia arabica, A. caesia, A. pennata, A. sinuata. A. mearnsii, A. picnantha, A. dealbata, A. auriculformis, A. holoserecia and A. mangium.

13. A method for alleviating joint pain and stiffness and improving mobility, range of motion and flexibility and physical function comprising administering to a host in need thereof an effective amount of a composition comprised of a mixture of an extract derived from Scutellaria enriched for Free-B-ring flavonoids containing baicalin, and an extract derived from Acacia enriched for flavans containing catechin or epicatechin, and one or more of an adjuvant, excipient or carrier; wherein said adjuvant, excipient or carrier is selected from the group consisting of calcium-based salts, silica, boron, histidine, glucosamine sulfate, chondroitin sulfate, copper gluconate, cellulose, vitamin D, and shark and bovine cartilage, wherein said method alleviates inflammation.

14. A method for treating pathological conditions related to osteoarthritis and rheumatoid arthritis comprising administering to a host in need thereof an effective amount of a composition comprised of a mixture of an extract derived from Scutellaria enriched for Free-B-ring flavonoids containing baicalin, and an extract derived from Acacia enriched for flavans containing catechin or epicatechin, and one or more of an adjuvant, excipient or carrier; wherein said adjuvant, excipient or carrier is selected from the group consisting of calcium-based salts, silica, boron, histidine, glucosamine sulfate, chondroitin sulfate, copper gluconate, cellulose, vitamin D, and shark and bovine cartilage, wherein said method alleviates inflammation.

15. A method for alleviating joint pain and stiffness and improving mobility, range of motion and flexibility and physical function comprising administering to a host in need thereof an effective amount of a composition prepared by a method comprising:

a) mixing an extract of a plant derived from Scutellaria enriched for Free-B-Ring flavonoids containing baicalin and an extract of a plant derived from Acacia enriched for flavans containing catechin or epicatechin to form a mixture; and

b) adding to said mixture one or more of an adjuvant, excipient or carrier to form said composition, wherein said method alleviates inflammation.

16. The method of claim 15 wherein said adjuvant, excipient or carrier is selected from the group consisting of calcium-based salts, silica, boron, histidine, glucosamine sulfate, chondroitin sulfate, copper gluconate, cellulose, vitamin D, and shark and bovine cartilage.

17. A method for treating pathological conditions related to osteoarthritis and rheumatoid arthritis comprising administering to a host in need thereof an effective amount of a composition prepared by a method comprising:

a) mixing an extract of a plant enriched for Free-B-Ring flavonoids containing baicalin and an extract of a plant enriched for flavans containing catechin or epicatechin to form a mixture; and

b) adding to said mixture one or more of an adjuvant, excipient or carrier to form said composition, wherein said method alleviates inflammation.

18. The method of claim 17 wherein said adjuvant, excipient or carrier is selected from the group consisting of calcium-based salts, silica, boron, histidine, glucosamine sulfate, chondroitin sulfate, copper gluconate, cellulose, vitamin D, and shark and bovine cartilage.

Assignments (2)
CHANGE OF NAME Recorded Oct 4, 2011
From: UNIGEN PHARMACEUTICALS, INC.
To: UNIGEN, INC.
Reel/Frame 027015/0720 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 22, 2003
From: JIA, QI
To: UNIGEN PHARMACEUTICALS, INC.
Reel/Frame 013823/0096 →
Continuity (2)
Provisional Application 6037716800 · Apr 30, 2002
Related Publication 20030216481A1 · Nov 20, 2003